Share Prices & Company Research

Stockbroking

Puretech Health Plc

Current Price 346.00p Bid 340.50p Ask 346.00p Change 1.62%
Last Updated: 25/07/2021 19:44. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Company Overview

PureTech Health plc ("PureTech Health", "PureTech" or "the Company") is a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic and immunological conditions, intractable cancers, lymphatic and gastrointestinal diseases and neurological and neuropsychological disorders, among others.

Financial Highlights Year Ended 31/12/2019

Revenue
£9.81m
Operating Profit/Loss
£-135.40m
Dividend yield (%)
n/a
Total dividend for year
$n/a
Dividend cover
n/a
P/E Ratio
2.90

Key Personnel

Ms. Daphne Zohar
Chief Executive Officer
Mr Bharatt Chowrira
Executive Director
Dr. John LaMattina
Independent Non-Executive Director
Dr. Raju Kucherlapati
Independent Non-Executive Director
Mr Christopher Viehbacher
Independent Non-Executive Director
Ms Kiran Mazumdar Shaw
Independent Non-Executive Director
Dr. Robert Langer
Non-Executive Director
Ms Dame Marjorie Scardino
Senior Independent Director

Stock Details

EPIC
PRTCL
ISIN
GB00BY2Z0H74
Shares in Issue
237.39m
Market cap
£821.36m

Analyst Views (2)

Strong Buy
 
0%
Buy
 
100.00%
Hold
 
0%
Sell
 
0%
Strong Sell
 
0%
This information is provided by Web Financial Group (UK) Limited. It is subject to change without notice and doesn't reflect the views held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
346.00p
Bid Price
340.50p
Ask Price
346.00p
Volume
3,947
Change Today
5.50p
% Change Today
1.62%
Open
346.00p
Previous Close
346.00p
Intraday High
346.75p
Intraday Low
345.50p
52 Week High
426.00p
52 Week Low
235.50p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart

Income Statement

Year End Date
31 Dec 2019
31 Dec 2018
 
$ (M)
$ (M)
Continuing Operations
Revenue
9.81
20.75
Operating Profit/Loss
-135.40
-104.02
Net Interest
-46.15
25.92
Pre-Tax Profit
478.47
-68.44
Profit After Tax from continuing operations
366.06
-70.66
Discontinued Operations
Profit After Tax
n/a
n/a
Profit/Loss for the Year
366.06
-70.66
Attributable to:
Equity Holders of Parent Company
421.14
-43.65
Minority Interests
-55.08
-27.00
Total Dividend Paid
$n/a
$n/a
Retained Profit/(Loss) for the Financial Year
n/a
n/a

Earnings per Share

Year End Date
31 Dec 2019
31 Dec 2018
Basic
149.00c
-16.00c
Diluted
144.00c
-16.00c
Adjusted
149.00c
-16.00c
Dividend per Share
$n/a
$n/a

Assets

Year End Date
31 Dec 2019
31 Dec 2018
 
$ (M)
$ (M)
Non-Current Assets
Property, Plant & Equipment
43.84
8.32
Intangible Assets
0.62
3.08
Investment Properties
n/a
n/a
Investments
725.55
169.75
Other Financial Assets
n/a
n/a
Other Non-Current Assets
2.32
0.82
Current Assets
Inventories
n/a
n/a
Trade & Other Receivables
4.27
6.71
Cash at Bank & In Hand
132.36
117.05
Current Asset Investments
30.09
133.83
Other Current Assets
2.12
2.20
Other Assets
n/a
n/a
Total Assets
941.18
441.76

Liabilities

Year End Date
31 Dec 2019
31 Dec 2018
 
$ (M)
$ (M)
Current Liabilities
Borrowings
1.46
12.01
Other Current Liabilities
137.75
253.75
Total Current Liabilities
139.20
265.76
Non-Current Liabilities
Borrowings
34.91
n/a
Provisions
115.44
6.43
Other Non-Current Liabilities
1.22
2.60
Total Non-Current Liabilities
151.58
9.03
Other Liabilities
n/a
n/a
Total Liabilities
290.78
274.79

Net Assets

Year End Date
31 Dec 2019
31 Dec 2018
 
$ (M)
$ (M)
Net Assets
650.40
166.97

Capital & Reserves

Year End Date
31 Dec 2019
31 Dec 2018
 
$ (M)
$ (M)
Share Capital
5.41
2.38
Share Premium Account
287.96
278.39
Other Reserves
120.22
162.44
Retained Earnings
254.44
-167.69
Shareholders Funds
668.04
275.51
Minority Interests/Other Equity
-17.64
-108.53
Total Equity
650.40
166.97

Dividend History

Dividend Metrics

Year End Date
31 Dec 2019
31 Dec 2018
Dividend growth
n/a%
n/a%
Dividend yield
n/a%
n/a%
Dividend cover
n/a
n/a


Cboe Global Markets® is a registered trade mark of Cboe Global Markets, Inc., a company incorporated in the United States of America with registered address at 400 South LaSalle Street, Chicago, IL 60605, USA. Cboe shall own any and all rights including without limitation Intellectual Property rights and any and all goodwill arising directly or indirectly out of the Recipient’s use of the “Cboe Global Markets®”, “Cboe®” and “Bats®”” trademarks. Neither Cboe nor its licensors accept any liability for any errors or omissions in the Cboe Europe Indices or underlying data. No further distribution of Cboe Europe data is permitted without Cboe’s express written consent.

The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
Continuing our Personal Service: View our Latest COVID-19 Update: 15th July 2021
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.